For over two decades, the federal government has issued directives and regulations to protect critical infrastructure from cybercrime. But as attacks on healthcare, manufacturing and the supply chain rage on, are these regulations doing enough to protect the industries we rely on?
In the latest Imprivata Live session, experts from our legal and product teams dive into vendor access risks, as well as strategies and best practices to mitigate them…
Imprivata had an incredible 2018 and the momentum continues to build as we look towards HIMSS19 (February 11-15 in Orlando, FL) where we’ll be debuting innovative identity and access management solutions to enhance our healthcare security platform. We’re excited to see that many of our customers will be sharing their experiences and tips for success through presentations in the theater at our booth and on the HIMSS stage. You’ll also see us up and down that aisles of the exhibition hall as our technology ecosystem partners will be displaying Imprivata interoperability in their booths.
I know where I’ll be, at Imprivata HealthCon! The Imprivata HealthCon 2012 User Conference kicks off with an evening event on Tuesday, November 6th followed by two days of Healthcare IT sessions on topics such as EMR Adoption, HIPAA/HITECH compliance and Stage 2 Meaningful Use.
The U.S. Drug Enforcement Agency (DEA) should increase the use of electronic prescribing for controlled substances (EPCS), according to one of the 56 recommendations presented to President Donald Trump on Wednesday by The Commission on Combating Drug Addiction and the Opioid Crisis.